Primary therapy and survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma: a population-based analysis in the Netherlands, 1993-2016

被引:13
|
作者
Posthuma, Hidde L. A. [1 ]
Zijlstra, Josee M. [1 ]
Visser, Otto [2 ]
Lugtenburg, Pieternella J. [3 ]
Kersten, Marie Jose [4 ,5 ]
Dinmohamed, Avinash G. [1 ,4 ,6 ,7 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam UMC, Canc Ctr Amsterdam, Dept Haematol, Amsterdam, Netherlands
[2] Netherlands Comprehens Canc Org IKNL Utrecht, Dept Registrat, Utrecht, Netherlands
[3] Erasmus MC Canc Inst, Dept Haematol, Rotterdam, Netherlands
[4] Univ Amsterdam, Amsterdam UMC, Canc Ctr Amsterdam, Dept Haematol, Amsterdam, Netherlands
[5] Lymphoma & Myeloma Ctr Amsterdam LYMMCARE, Amsterdam, Netherlands
[6] Netherlands Comprehens Canc Org IKNL, Dept Res, Utrecht, Netherlands
[7] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands
关键词
nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL); cancer epidemiology; population-based registry; incidence; survival;
D O I
10.1111/bjh.16290
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this nationwide, population-based study, we assessed trends in primary treatment and survival among 687 patients with nodular lymphocyte-predominant Hodgkin lymphoma (75% males; median age, 40 years; and 74% stage-I/II disease) diagnosed in the Netherlands between 1993-2016. There were no noteworthy changes in the application of primary therapy over time among adult patients across the different disease stages and age groups. Survival among various subgroups of adult patients was largely comparable to the expected survival of the general population. A particularly encouraging finding was that young adult patients experienced virtually no excess mortality, as compared to the general population.
引用
收藏
页码:117 / 121
页数:5
相关论文
共 50 条
  • [1] Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands
    Hidde L. A. Posthuma
    Josée M. Zijlstra
    Otto Visser
    Marie José Kersten
    Pieternella J. Lugtenburg
    Avinash G. Dinmohamed
    Blood Cancer Journal, 11
  • [2] Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands
    Posthuma, Hidde L. A.
    Zijlstra, Josee M.
    Visser, Otto
    Kersten, Marie Jose
    Lugtenburg, Pieternella J.
    Dinmohamed, Avinash G.
    BLOOD CANCER JOURNAL, 2021, 11 (05)
  • [3] Characteristics and Outcomes of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Versus Those With Classical Hodgkin Lymphoma: A Population-Based Analysis
    Gerber, Naamit K.
    Atoria, Coral L.
    Elkin, Elena B.
    Yahalom, Joachim
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (01): : 76 - 83
  • [4] ANALYSIS OF PATIENTS DIAGNOSED OF NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN'S LYMPHOMA
    Pilar, A.
    Fernandez, R.
    Solano, J.
    Alonso Nogues, E.
    Zanabilli, Y.
    Alonso, J. M.
    Payer, A. R.
    Vicente, J. M.
    Medina, J.
    Taboada, F.
    Vargas, M.
    Alarcon, C.
    Moran, M.
    Gonzalez-Ordonez, A.
    Palicio, M. A.
    Ortiz, S.
    Chamorro, C.
    HAEMATOLOGICA, 2014, 99 : 680 - 681
  • [5] Characteristics and Outcomes of Patients With Lymphocyte-Predominant Hodgkin Lymphoma Versus Classical Hodgkin Lymphoma: A Population-Based Analysis
    Gerber, N.
    Atoria, C. L.
    Elkin, E. B.
    Yahalom, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S153 - S154
  • [6] Primary nodular lymphocyte-predominant Hodgkin lymphoma of uterine cervix mimicking leiomyoma
    Li, Wan-Shan
    Wang, Ren-Ching
    Wang, John
    Chang, Kung-Chao
    CLINICAL CASE REPORTS, 2015, 3 (06): : 349 - 352
  • [7] Adult nodular lymphocyte-predominant Hodgkin lymphoma: treatment modality utilization and survival
    Alonso, Clayton
    Dutta, Sunil W.
    Mitra, Nandita
    Landsburg, Daniel J.
    Zaorsky, Nicholas G.
    Grover, Surbhi
    Peterson, Jennifer
    Trifiletti, Daniel M.
    CANCER MEDICINE, 2018, 7 (04): : 1118 - 1126
  • [8] Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma
    Porrata, Luis F.
    Ristow, Kay
    Habermann, Thomas M.
    Witzig, Thomas E.
    Colgan, Joseph P.
    Inwards, David J.
    Ansell, Stephen M.
    Micallef, Ivana N.
    Johnston, Patrick B.
    Nowakowski, Grzegorz S.
    Thompson, Carrie
    Markovic, Svetomir N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (03) : 321 - 330
  • [9] Early-Stage Nodular Lymphocyte-Predominant Hodgkin Lymphoma: The Impact of Radiation Therapy on Overall Survival
    Parikh, R. R.
    Grossbard, M. L.
    Harrison, L. B.
    Yahalom, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S81 - S81
  • [10] MULTICENTER RETROSPECTIVE STUDY OF PATIENTS WITH NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN'S LYMPHOMA
    Diaz, Galvez F. J.
    Gonzalez, Rodriguez A. P.
    Ramila, Herrero M. E.
    Rodriguez, Izquierdo A.
    Bastos, Oreiro M.
    Campuzano, Saavedra, V
    Vidal, Mancedino M. J.
    Moreno, Velazquez M.
    Gutierrez, Villafuerte P.
    Velez, Tienza P.
    Hernandez, Mohedo F.
    De Cabo, Lopez E.
    Lopez, Jimenez J.
    Pardal, de la Mano E.
    Perez, de Oteyza J.
    Garcia, Belmonte D.
    Herraez, Balanzat, I
    Garcia, Sanz R.
    HAEMATOLOGICA, 2020, 105 : 292 - 293